View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
March 10, 2011

New Test Effective in Identifying Common STI

A new assay could provide an effective way of identifying Trichamonos vaginalis, a common sexually transmitted infection, a study carried out at Rhode Island Hospital in the US has revealed. Researchers compared the new test, the Aptima Assay, with the Affirm assay, the only U

By cms admin

A new assay could provide an effective way of identifying Trichamonos vaginalis, a common sexually transmitted infection, a study carried out at Rhode Island Hospital in the US has revealed.

Researchers compared the new test, the Aptima Assay, with the Affirm assay, the only US Food and Drug Administration (FDA) approved diagnostic test for identifying pathogens associated with bacterial vaginitis.

The study evaluated 766 women, and the results showed that the Affirm assay produced both false positive and false negative results. However, the Aptima assay detected 36% more infected women, and yielded a sensitivity of 100% with no false positives.

The Aptima assay uses a special type of amplification to detect Trichamonos vaginalis.

The Aptima assay has been submitted to the FDA for approval.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management